Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 50 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10220046

    Compositions and methods for disease treatment using nanoparticle delivered compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  2. US 10214726

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  3. US 10213478

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  4. US 10215762

    Method to optimize the treatment of patients with biological drugs

    PROGENIKA BIOPHARMA, S.A. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  5. US 10213395

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  6. US 10214529

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  7. US 10208059

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  8. US 10206933

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  9. US 10206877

    Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  10. US 10202449

    Cachexia treatment

    XBIOTECH INC. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  11. US 10201596

    Peptide conjugated particles for the treatment of allergy

    Northwestern University · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  12. US 10201547

    Method of treatment of aggression

    Supernus Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  13. US 10202412

    β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections

    Atea Pharmaceuticals, Inc. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  14. US 10196443

    TEM8 antibodies and their use in treatment and detection of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  15. US 10195259

    Compositions and methods for treatment of cancer using bacteria

    Decoy Biosystems, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  16. US 10195168

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  17. US 10188635

    Use of gaboxadol in the treatment of tinnitus

    OVID THERAPEUTICS INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  18. US 10188650

    Treatment of neurological disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  19. US 10188656

    Methods of treatment of malignancies

    Agios Pharmaceuticals, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  20. US 10182997

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  21. US 10183055

    Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  22. US 10184004

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  23. US 10183942

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  24. US 10179912

    RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

    BIOMARIN TECHNOLOGIES B.V. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.